Global Pharma Labs, Inc. is a pharmaceutical company. The San Leandro, California-based company is focused on developing solutions for disease processes in patients. Our technology, OA-SYSâ˘, is the first disease-modifying therapy for osteoarthritis, a disease which affects around 55 million people in the USA and approximately 750 million people globally. Global Pharma Labs Inc.âs first drug product, OA-SYSâ˘, will impact those that suffer with osteoarthritis. The immediate impact will be most apparent in developing countries where surgical joint replacement and joint injection therapy is not a practical treatment option for the vast majority of those suffering with the disease. OA-SYS⢠is the first disease modifying medication treatment for osteoarthritis. There are no competitors. Present medication treatment of osteoarthritis is limited to pain medicines which afford only temporary relief of pain, joint injections of steroids which affords only temporary relief of pain within the injected joint, and joint injections of Hyaluronic acid which also affords only temporary relief of pain within the injected joint. Global Pharma Labs Inc. has exclusive patent rights to the first disease modifying medication treatment for osteoarthritis. This patented treatment affords long term relief of joint pain, long term relief of joint stiffness, long term diminution of physical limitations, long term improvement in the ability to perform activities of daily living, reduction or elimination in the need for pain medications, and reduction or elimination in the need for invasive treatment such as joint replacement and joint injections. This treatment is disease modifying, noninvasive, nonnarcotic, and relatively inexpensive.
No articles found.
AngioDynamics is a leading provider of innovative medical devices used by interven...
AngioDynamics is a leading provider of innovati...
slumberBUMP⢠was invented by Dr. Shad Morris, DMD from Premier Sleep Solutions. ...
slumberBUMP⢠was invented by Dr. Shad Morris,...
For more than 40 years, IntriCon has been meeting the rising demand for smaller, p...
For more than 40 years, IntriCon has been meeti...
Evogene (NASDAQ, TASE: EVGN) is a leading biotechnology company developing novel p...
Evogene (NASDAQ, TASE: EVGN) is a leading biote...
Healing Budz is a social healing platform created with the purpose of spreading kn...
Healing Budz is a social healing platform creat...
Gritstone Oncology is developing tumor-specific cancer immunotherapies to fight mu...
Gritstone Oncology is developing tumor-specific...
Kitov Pharma is an innovative biopharmaceutical drug development company. Leveragi...
Kitov Pharma is an innovative biopharmaceutical...
Flexion Therapeutics is a biopharmaceutical company focused on the development and...
Flexion Therapeutics is a biopharmaceutical com...
Exicure, Inc. is a clinical stage biotechnology company developing a new class of ...
Exicure, Inc. is a clinical stage biotechnology...
Join the National Investor Network and get the latest information with your interests in mind.